Treatment modality affects long-term quality of life in gyaecological cancer.
2000 (English)In: Anticancer Research, ISSN 0250-7005, Vol. 20, no 1B, 563-568 p.Article in journal (Refereed) Published
In order to survey the side effects after cancer treatment, quality of life data were collected from females in clinical remission, Materials and Methods: The study was cross-sectional, every patient that visited the outpatient clinic during a period of thr ee months was asked to anonymously complete the EORTC QLQ-C30 questionnaire and five additional specific questions related to gynaecological cancel: Results: In total, 235 patients (90%) returned the questionnaire In general, both the levels of functioning and symptomatology were time-dependent. Patients with short treatment-free intervals reported more problems than the others. When wing treatment modality as an independent variable in the statistical calculations, a treatment-related effect on functioning and symptomatology was demonstrated (p < 0.05 to p < 0.001). Patients previously treated with chemotherapy had poorer role- and cognitive functioning and mole problems with fatigue, nausea, vomiting, dyspnoea, constipation and financial problems, compared with those not treated with chemotherapy (p < 0.05 to p < 0.01). Those patients who had been treated with external radiotherapy and/or brachytherapy had significantly more problems with flatulence and diarrhoea (p < 0.05 to p < 0.001). In conclusion, patients who underwent treatment for gl gynaecological cancer reported long-term side effects also many years after finishing treatment. The problems where related to treatment modality which should be considered, especially when planning adjuvant treatment.
Place, publisher, year, edition, pages
2000. Vol. 20, no 1B, 563-568 p.
gynaecological cancer, clinical omission, quality of life, side effects
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:liu:diva-25384Local ID: 9827OAI: oai:DiVA.org:liu-25384DiVA: diva2:245713